Artemether

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01BE02

CAS registry number (Chemical Abstracts Service)

0071963-77-4

Chemical Formula

C16-H26-O5

Molecular Weight

298

Therapeutic Category

Antiprotozoal agent: Antimalarial

Chemical Name

3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-,(3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12aR)-,(+)-

Foreign Names

• Artemetherum (Latin)
• Artemether (German)
• Artéméther (French)
• Artemero (Spanish)

Generic Names

• Artemether (OS: USAN, BAN)
• Artéméther (OS: DCF)
• Artemether (PH: Ph. Int. 4)
• Artemetherum (PH: Ph. Int. 4)

Brand Names

• Artem
  Kunming Dihon P'cal, Myanmar



• Coartem (Artemether and Lumefantrine)
  Novartis, Burkina Faso; Novartis, Benin; Novartis, Central African Republic; Novartis, Congo; Novartis, Cote D'ivoire; Novartis, Cameroon; Novartis, Gabon; Novartis, Guinea; Novartis, Indonesia; Novartis, Madagascar; Novartis, Mali; Novartis, Mauritania; Novartis, Niger; Novartis, Senegal; Novartis, Chad; Novartis, Togo; Novartis, United States; Novartis, South Africa; Novartis, Zaire; Novartis Consumer Health, Peru



• Larither
  Ipca, India; Ipca, Myanmar



• Paluther
  Aventis, Ghana; Aventis, Kenya; Aventis, Nigeria; Aventis, Zimbabwe; Howse & McGeorge, Uganda; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, Brazil



• Riamet (Artemether and Lumefantrine)
  Novartis, Australia; Novartis, Belgium; Novartis, Bulgaria; Novartis, Switzerland; Novartis, Germany; Novartis, France; Novartis, United Kingdom; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Poland; Novartis, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.